Business

Crestron launches new Microsoft Teams scheduling panels

Crestron adds Teams software to its new 70 Series hardware to create a workplace solution that gives on-site employees comprehensive, real-time control over their office environment. ROCKLEIGH, N.J.–(BUSINESS WIRE)–Crestron, the global leader in workplace technology, today announces the new Crestron 70 Series

Business, Health Care

Legend Biotech announces Phase 1b/2 study data of cilta-cel, an investigational BCMA CAR-T, showing early, deep, and durable responses in heavily pretreated patients with multiple myeloma

Combined Phase 1b/2 CARTITUDE-1 study presented at ASH 2020 Annual Meeting show 97 percent overall response rate and 12-month progression free survival rate of 77 percent at median follow up of 12.4 months SOMERSET, N.J.–(BUSINESS WIRE)–Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”),

Business

AM Best affirms credit ratings of Anthem, Inc. and its subsidiaries

OLDWICK, N.J.–(BUSINESS WIRE)–AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a+” of the core Blue Cross Blue Shield-branded insurance subsidiaries of Anthem, Inc. (Anthem) (Indianapolis, IN) [NYSE:ANTM]. Concurrently, AM

Business, Media & Communications

Semperis appoints Rob Porell as Chief Financial Officer

Proven Financial Executive to Focus on Building Financial Strategy and Infrastructure to Support the Rapid Expansion of East Coast-Based Cybersecurity Leader NEW YORK–(BUSINESS WIRE)–#accounting—Semperis, the pioneer of identity-driven cyber resilience for enterprises, today announced the appointment of Rob Porell as its CFO.

Business, Health Care

Janssen submits application to U.S. FDA seeking approval of amivantamab for the treatment of patients with metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations

Expanded Access Program Established for Patients in the U.S. Who May Benefit from Investigational Therapy While Application is Under Review RARITAN, N.J.–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a Biologics License Application (BLA) to the